FORTRESS BIOTECH INC - COM (FBIO)

CUSIP: 34960Q109

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / COM
Total 13F shares
30,820,541
Share change
-4,728,286
Total reported value
$25,882,668
Put/Call ratio
18%
Price per share
$0.84
Number of holders
60
Value change
-$4,832,922
Number of buys
28
Number of sells
47

Quarterly Holders Quick Answers

What is CUSIP 34960Q109?
CUSIP 34960Q109 identifies FBIO - FORTRESS BIOTECH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FORTRESS BIOTECH INC - COM (FBIO) as of Q2 2022

As of 30 Jun 2022, FORTRESS BIOTECH INC - COM (FBIO) was held by 60 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,820,541 shares. The largest 10 holders included Nantahala Capital Management, LLC, VANGUARD GROUP INC, TANG CAPITAL MANAGEMENT LLC, Opaleye Management Inc., BlackRock Inc., Oasis Management Co Ltd., MILLENNIUM MANAGEMENT LLC, SHIKIAR ASSET MANAGEMENT INC, CPWM, LLC, and PERKINS CAPITAL MANAGEMENT INC. This page lists 60 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.